While Stearyl coenzyme A desaturase 1 (SCD1) can promote TFEB-mediated lipophagy to interfere with foam cell formation and modulation of the SCD1/TFEB machinery may offer novel therapeutic approaches for atherosclerosis (Pi et al., 2019). This evidence concerns the gene TFEB and atherosclerosis.